Novartis may be launching an array of vehicles to shuttle drugs across the blood-brain barrier, but executives told Fierce ...
Aerska, which uses brain shuttle technology to deliver RNAi therapeutics to the brain, announced the close of a $39 million Series A financing round, bringing its total funding to $60 million. EQT ...
Our brain is a fortress. Its delicate interior is completely surrounded by a protective wall called the blood-brain barrier. True to its name, the barrier separates contents in the blood and the brain ...
Alector’s updated analyst framework now points to a fair value move from US$2.88 to US$3.10, a modest shift that still signals a meaningful recalibration of expectations. This change is closely tied ...
Novartis has agreed to pay up to $1.7 billion to license an experimental Alzheimer’s therapy from China-based SciNeuro, a megadeal that signals how aggressively big pharma is now chasing ...
Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s platform R&D Lisa Taylor Ash joins Board of Directors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results